Highbridge Capital Management LLC Buys 83,200 Shares of Amedisys, Inc. (NASDAQ:AMED)

Highbridge Capital Management LLC raised its position in Amedisys, Inc. (NASDAQ:AMED) by 34.7% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 323,200 shares of the health services provider’s stock after buying an additional 83,200 shares during the quarter. Highbridge Capital Management LLC owned about 0.99% of Amedisys worth $29,670,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in AMED. Alpine Associates Management Inc. lifted its stake in shares of Amedisys by 0.9% during the 2nd quarter. Alpine Associates Management Inc. now owns 1,280,897 shares of the health services provider’s stock valued at $117,586,000 after buying an additional 11,000 shares in the last quarter. Park West Asset Management LLC lifted its position in shares of Amedisys by 8.0% during the fourth quarter. Park West Asset Management LLC now owns 812,069 shares of the health services provider’s stock worth $77,195,000 after acquiring an additional 60,350 shares in the last quarter. Water Island Capital LLC boosted its holdings in shares of Amedisys by 185.0% in the fourth quarter. Water Island Capital LLC now owns 710,697 shares of the health services provider’s stock worth $67,559,000 after acquiring an additional 461,368 shares during the period. Dimensional Fund Advisors LP grew its position in shares of Amedisys by 4.0% in the second quarter. Dimensional Fund Advisors LP now owns 514,166 shares of the health services provider’s stock valued at $47,202,000 after purchasing an additional 19,660 shares in the last quarter. Finally, Calamos Advisors LLC raised its stake in shares of Amedisys by 11.6% during the 2nd quarter. Calamos Advisors LLC now owns 397,347 shares of the health services provider’s stock valued at $36,476,000 after purchasing an additional 41,220 shares during the period. Hedge funds and other institutional investors own 94.36% of the company’s stock.

Amedisys Stock Down 0.2 %

Shares of NASDAQ AMED opened at $97.15 on Thursday. The company has a current ratio of 1.16, a quick ratio of 1.16 and a debt-to-equity ratio of 0.30. The business has a 50-day moving average of $97.74 and a 200-day moving average of $94.75. The firm has a market capitalization of $3.17 billion, a price-to-earnings ratio of -151.80, a PEG ratio of 1.89 and a beta of 0.78. Amedisys, Inc. has a 12 month low of $89.55 and a 12 month high of $98.95.

Amedisys (NASDAQ:AMED) last released its quarterly earnings results on Wednesday, July 24th. The health services provider reported $1.32 EPS for the quarter, topping analysts’ consensus estimates of $1.22 by $0.10. The business had revenue of $591.19 million during the quarter, compared to analysts’ expectations of $579.34 million. Amedisys had a net margin of 4.02% and a return on equity of 12.39%. Sell-side analysts expect that Amedisys, Inc. will post 4.66 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on AMED. William Blair lowered Amedisys from an “outperform” rating to a “market perform” rating in a report on Monday, July 1st. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $101.00 price objective on shares of Amedisys in a research note on Thursday, July 25th. Finally, Deutsche Bank Aktiengesellschaft cut shares of Amedisys from a “buy” rating to a “hold” rating and set a $101.00 target price on the stock. in a research note on Monday, July 29th. Four research analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat, Amedisys presently has a consensus rating of “Hold” and an average price target of $100.67.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.